Clinical Values of Mature Fistulas in Hemodialysis

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04416971

Enrollment

100

Registered

2020-06-04

Start date

2020-08-20

Completion date

2021-11-20

Last updated

2020-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemodialysis Access Failure, Hemodialysis Complication

Brief summary

The arteriovenous fistula (AVF) is the preferred vascular access for hemodialysis(HD), and fistula-first is the general recommendation for all HD patients. But in clinical practice in China, quite a few patients start HD before AVF maturation due to various situations. Whether HD initiation with mature AVF will influence the patency and complications is controversial. This study is aim to compare the AVF patency in incident HD patients with mature or immature AVF on HD initiation, and to compare other clinical outcomes, including abandonment without use, infection, and other AVF complications occurrence.

Interventions

PROCEDUREAVF puncture

For patients with mature/immature AVF on HD initiation, AVF puncture will be conducted.

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 80 Years

Healthy volunteers

Inclusion criteria

* underwent initial upper-extremity AVF creation for incident HD at Zhongshan Hospital, Fudan University

Exclusion criteria

* with malignancies * not followed-up at Zhongshan Hospital, Fudan University

Design outcomes

Primary

Measure	Time frame	Description
AVF patency	June 2020 to June 2021	A functional AVF was defined as allowing at least six adequate HD sessions without any AVF-related complications. Primary AVF patency was defined as the interval from HD initiation via a functional AVF to any intervention designed for maintenance or reestablishment of AVF function, AVF failure, or study end, whichever occurred first, and secondary AVF patency was defined as the interval from HD initiation via an AVF until the termination of HD via AVF due to any cause, regardless of the number of subsequent interventions.

Secondary

Measure	Time frame	Description
Abandonment without use, infection, and other complications of AVF creation.	June 2020 to June 2021	Abandonment without use, infection, and other complications of AVF creation.

Countries

China

Contacts

Primary Contactbo shen, MD

shen.bo@zs-hospital.sh.cn+86-13795307471

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026